Category: Long COVID
The epidemiology of long COVID in US adults
(Clinical Infectious Diseases) We estimated the prevalence of long COVID and impact on daily living among a representative sample of adults in the United States (US). We conducted a population-representative survey, June 30-July 2, 2022, of a random sample of 3,042 United States adults aged 18 years or older and weighted to the 2020 US […]
Dec 27, 2022
5 big questions we still need to answer about long covid (Opinion)
(Washington Post) We are nearly three years into the covid-19 pandemic, and the debate about the need for health measures such as vaccine and mask mandates is as hot as ever. One big reason for that: long covid. What even is “long covid”? Broadly speaking, the condition refers to any symptoms persisting weeks to months after […]
Dec 27, 2022
Long COVID: Could mono virus or fat cells be playing roles?
(AP) A British historian, an Italian archaeologist and an American preschool teacher have never met in person, but they share a prominent pandemic bond. Plagued by eerily similar symptoms, the three women are credited with describing, naming and helping bring long COVID into the public’s consciousness in early 2020.
Dec 27, 2022
Are Subphenotypes for Long COVID Beneficial?
(MedPageToday) A recent study opens in a new tab or window published in Nature Medicine, “Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes” by Hao Zhang, PhD, et al. used a data-driven framework to stratify patients suffering with post-acute SARS-CoV-2 (PASC), also referred to as long COVID, into different subcategories of sequelae. The bulk of the patients in the […]
Dec 20, 2022
Scientists’ understanding of long covid is improving
(Economist) PODCAST Our podcast on science and technology. This week, we examine the latest research into what may be causing long covid, and ask whether the hunt for answers could shed light on other chronic conditions. SOON AFTER the pandemic began, another health crisis started to emerge. Long covid now affects millions of people around the world. […]
Dec 13, 2022
New VA study finds Paxlovid may cut the risk of long COVID
(NPR) It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop severe illness. Now, researchers from the Veterans Health Administration find that taking the medication may also reduce the risks of later developing long COVID, according […]
Nov 8, 2022
Pfizer’s Paxlovid Antiviral Lowered Long-Covid Risk in Study
(Bloomberg) Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long Covid, a study found.Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering […]
Nov 7, 2022
A Reporter in Search of Long Covid’s Impact
(Bloomberg Prognosis/Jason Gale) While the evidence is still emerging, what’s clear already is that the social and economic impacts are profound. Harvard economist David Cutler puts the cost of long Covid at $3.7 trillion in the US alone. And the condition could impair more than 140 million people worldwide.
Nov 3, 2022
U.S. government to test Pfizer’s Paxlovid for long COVID
(Reuters) The U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday. The complex medical condition involves more than 200 symptoms ranging from exhaustion and cognitive impairment to pain, fever and […]
Oct 28, 2022
Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study
(Nature) The immune-inflammatory response during the acute phase of COVID-19, as assessed using peak body temperature (PBT) and peripheral oxygen saturation (SpO2), predicts the severity of chronic fatigue, depression and anxiety symptoms 3–4 months later.
Oct 24, 2022